NovoCure (NVCR) Shareholder's Equity (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.86% |
| Dec 31, 2025 | -0.25% |
| Sep 30, 2025 | -2.32% |
| Jun 30, 2025 | -3.46% |
| Mar 31, 2025 | 0.49% |
| Dec 31, 2024 | -0.17% |
| Sep 30, 2024 | -0.27% |
| Jun 30, 2024 | 0.67% |
| Mar 31, 2024 | -0.87% |
| Dec 31, 2023 | -7.93% |
| Sep 30, 2023 | -5.29% |
| Jun 30, 2023 | -3.81% |
| Mar 31, 2023 | -2.05% |
| Dec 31, 2022 | -0.95% |
| Sep 30, 2022 | 0.84% |
| Jun 30, 2022 | 1.33% |
| Mar 31, 2022 | 6.18% |
| Dec 31, 2021 | -0.65% |
| Sep 30, 2021 | 4.00% |
| Jun 30, 2021 | 6.75% |
| Mar 31, 2021 | -21.91% |
| Dec 31, 2020 | 55.20% |
| Sep 30, 2020 | 14.64% |
| Jun 30, 2020 | 10.69% |
| Mar 31, 2020 | 11.09% |
| Dec 31, 2019 | 14.41% |
| Sep 30, 2019 | 19.80% |
| Jun 30, 2019 | 25.72% |
| Mar 31, 2019 | 12.59% |
| Dec 31, 2018 | -2.33% |
| Sep 30, 2018 | 2.55% |
| Jun 30, 2018 | 5.62% |
| Mar 31, 2018 | -6.56% |
| Dec 31, 2017 | -2.67% |
| Sep 30, 2017 | -0.73% |
| Jun 30, 2017 | -8.81% |
| Mar 31, 2017 | -9.45% |
| Dec 31, 2016 | -10.05% |
| Sep 30, 2016 | -15.22% |
| Jun 30, 2016 | -15.32% |
| Mar 31, 2016 | -12.12% |
| Dec 31, 2015 | 106.91% |